Atlas Trials

Childhood Solid Neoplasm

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Childhood Solid Neoplasm

RecordFirmDate
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02975882)Children's Oncology Group2017-08-15
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02808650)Children's Oncology Group2017-02-27
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 (NCT02775292)Jonsson Comprehensive Cancer Center2017-01-03
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies (NCT02116777)National Cancer Institute (NCI)2014-05-16
Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT01725191)National Cancer Institute (NCI)2012-10-01
Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia (NCT01445080)National Cancer Institute (NCI)2006-05-30
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer (NCT00898079)Children's Oncology Group2003-10-13

Track Childhood Solid Neoplasm automatically

Every clearance here is in the API, with alerts when new ones post.